🔴 Xenetic Biosciences is trading 5% down today

Xenetic Biosciences is trading 5.06% down now at $2.44, with no new company-specific announcement identified for September 23, 2026.

• The latest major development remains the September 16 Santersus merger, an all-stock transaction expected to leave existing shareholders with approximately 15% of the combined company and subject to approval.
• The release does not attribute the September 23 price movement to the deal.
• Broader markets are weaker, while biotechnology is outperforming; available evidence does not establish a sector or macro cause.